Make your money go further for just 25p per day

Tristel (AIM: TSTL) – brilliant results and all is looking good

25/02/2015 · Tristel (TSTL) 

The manufacturer of infection prevention, contamination control and hygiene products has announced terrific interim results for the six months ended 31 December 2014.

Revenue was up 15% to £7.4m including international sales up 26% to £2.4m, pre-tax profit before share based payments up 57% to £1.1m and basic EPS up 85% to 1.91p. 

The Group finished the period with net cash of £2.9m (2013: £1.5m)

Tristel’s lead technology is a proprietary Chlorine dioxide formulation addressing three distinct markets:

- The Human Healthcare market (hospital infection prevention - via the Tristel brand)
- The Contamination…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Tristel

Double digit growth | Stonking Small Cap updates

30/07/2025 · Company Insights

Our coverage here includes a review of stunning results from a manufacturer of products for the…


US approval | Successful sale | Angling success

14/05/2025 · Company Insights

News covered here includes our assessment of pleasing results from a specialist fishing tackle retailer, although…


More Company Insights

Hostel delights | Franchise mystery | Steady as ever

Neuroscience company with exciting potential

01/08/2025 · Cambridge Cognition

Sign-up to our free email updates

SIGN UP